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ischemia with subsequent reperfusion.1 Furthermore,
neonatal cardiac operations often necessitate deep
hypothermic circulatory arrest (DHCA), which results
M ost reparative cardiac surgical procedures requirecardiopulmonary bypass (CPB), which results in
an obligatory period of myocardial and pulmonary
Objective: Neutrophil adhesion to endothelium contributes to cardiopul-
monary dysfunction after cardiac surgical procedures. Initial neutrophil-
endothelial interactions involve selectins, which bind carbohydrate ligands,
such as sialyl-LewisX. Blockade of selectin-mediated neutrophil interactions
with CY1503, a synthetic oligosaccharide analog of sialyl-LewisX, could
limit neutrophil-mediated injury after cardiopulmonary bypass.
Methods: The efficacy of CY1503 treatment was tested in a lamb model of
cardiopulmonary bypass with hypothermic circulatory arrest. Neonatal
lambs received CY1503 (n = 6, CPB-CY1503) or saline solution vehicle (n
= 7, CPB-saline) into the pump prime before bypass and as a continuous
infusion throughout reperfusion. Five lambs served as control animals for in
vitro microvessel studies. Indexes of myocardial function (preload
recruitable stroke work index, and rate of pressure rise) and pulmonary func-
tion (compliance, airway resistance, and arterial PO2) were measured before
bypass and during reperfusion. The effect of CY1503 on endothelium-
dependent vascular reactivity was assessed by means of in vitro pulmonary
and coronary microvessel studies.
Results: Myocardial function was depressed after circulatory arrest, but
CY1503 preserved function near baseline (36% ± 25% vs 99% ± 19% of
baseline at 3 hours of reperfusion). CY1503-treated animals also demon-
strated improved pulmonary function during reperfusion. In vitro microves-
sel analysis of vascular reactivity revealed endothelial dysfunction after cir-
culatory arrest compared with control lambs. CY1503-treated lambs
(CPB-CY1503) had intact endothelial function, as demonstrated by normal
vasodilatory responses to endothelium-dependent vasodilators.
Conclusions: CY1503 preserves cardiopulmonary and endothelial function
after cardiopulmonary bypass and hypothermic circulatory arrest in neonatal
lambs. This suggests a role for selectin-mediated, neutrophil-endothelial
interactions in the inflammatory response after cardiac operations.  (J Thorac
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in whole body ischemia-reperfusion. These planned
periods of ischemia-reperfusion can initiate tissue and
vascular injury throughout the body, most notably in
the heart and lungs.2 Activation of inflammatory cas-
cades by the extracorporeal circuit may also contribute
to inflammatory injury after CPB.3
Interactions between leukocytes and vascular
endothelium are integral to various inflammatory dis-
orders, including ischemia-reperfusion injury. The
inflammatory events after cardiopulmonary support
are known to be neutrophil mediated.3 Corres-
pondingly, expression of a variety of leukocyte-
endothelial adhesion molecules is upregulated after
CPB.4,5 Neutrophil-endothelial interactions are a mul-
tistep process whereby adhesion molecules on both
leukocytes and vascular endothelium mediate the ini-
tial rolling and subsequent firm adhesion of leuko-
cytes to endothelial cells.6 The initial rolling of leuko-
cytes along the endothelial surface is mediated by the
selectins (P-, E-, and L-selectin), which recognize
fucosylated carbohydrate ligands on the neutrophil,
such as sialyl Lewisx antigen. The rolling of leuko-
cytes, which occurs at the onset of inflammation, is a
prerequisite for firm leukocyte adhesion and
transendothelial leukocyte migration.6
Prevention of leukocyte adhesion to the endothelium
may be a potential strategy to reduce the inflammation-
related morbidity of CPB by preventing reperfusion
injury to the heart, lungs, and other organs. Inhibition
of the initial selectin-mediated leukocyte-endothelial
interactions is intuitively attractive. In blood-perfused
isolated lamb hearts subjected to 2 hours of hypother-
mic ischemia followed by reperfusion, we have demon-
strated preservation of myocardial contractile function
by selectin blockade with either fucoidin7 or the syn-
thetic sialyl Lewisx analog CY1503 (unpublished data).
In other animal models of inflammation or ischemic
injury, administration of CY1503 has been shown to be
effective in reducing neutrophil accumulation and tis-
sue injury, including myocardial infarction,8-11 acute
lung injury,12-14 trauma,15 transplantation,12,16 and sep-
tic shock.13 Animal models of myocardial infarction
have demonstrated that CY1503 treatment before
reperfusion reduces infarct size, preserves contractile
function, and maintains normal coronary vascular reac-
tivity.8-10 In a similar manner we reasoned that admin-
istration of CY1503 might limit the inflammatory tis-
sue injury related to CPB with DHCA (CPB-DHCA).
Because circulatory support is commonly associated
with alterations in myocardial performance, pulmonary
function, and vascular reactivity postoperatively, the
present study was undertaken to determine whether
administration of CY1503 could preserve myocardial,
pulmonary, and vascular endothelial function in a
neonatal lamb model of CPB and circulatory arrest.
Material and methods
Experimental preparation. Neonatal lambs (age, 5-7
days; weight, 5-8 kg) were anesthetized with intramuscular
ketamine (40 mg/kg) and intubated. Mechanical ventilation
was instituted with a Servo 900C ventilator (Siemens,
Danvers, Mass) with tidal volumes of 15 mL/kg, a fraction
of inspired oxygen of 1.0, and 3 cm H2O positive end-expi-
ratory pressure. The respiratory rate was adjusted to main-
tain PCO2 between 35 and 45 mm Hg. After venous access
had been established, an induction dose of fentanyl (300
µg/kg) was given, and continuous infusions of fentanyl (50
µg · kg–1 · h–1), ketamine (5 mg · kg–1 · h–1), and midazolam
(0.5 mg · kg–1 · h–1) were begun and given throughout the
remainder of the experiment, excluding the circulatory arrest
period. Catheters were placed in the femoral artery and vein,
the left atrium, and the main pulmonary artery for hemody-
namic measurements and blood sampling. Sonomicrometry
crystals were placed on the epicardium of the left ventricular
free wall along the equatorial circumference for measurement
of myocardial segmental shortening.17 After systemic
heparinization (400 U/kg), a 5F vascular sheath was inserted
into the left ventricle through the apex for pressure measure-
ment with a pressure transducer (SPC-350; Millar
Instruments, Inc, Houston, Tex) and for venting during CPB.
The extracorporeal bypass circuit consisted of a standard
roller pump (Cardiovascular Instruments, Wakefield, Mass),
sterile new membrane oxygenator (VPCML, Cobe
Laboratories Inc, Lakewood, Colo), and sterile new tubing.
The pump prime consisted of 200 mL of Normosol solution
and 500 mL of homologous donor blood (hematocrit value,
~20%) warmed to 37°C.
Experimental procedure. After baseline ventricular and
pulmonary function measurements had been recorded, CPB
was instituted at 150 mL · kg–1 · min–1 through an 8F arterial
cannula placed in the right femoral artery and a 24F venous
cannula placed in the right atrium. After 5 minutes of nor-
mothermic CPB, phentolamine hydrochloride (0.2 mg/kg)
was given, systemic cooling was begun, and the esophageal
temperature was lowered to 15°C over 25 minutes by the pH-
stat blood gas strategy. A 2-hour period of hypothermic cir-
culatory arrest followed, with additional topical cooling of
the heart with saline solution at 4°C. CPB was reinitiated
after 2 hours of circulatory arrest, and the animals were
rewarmed to an esophageal temperature of 35°C over 30 min-
utes. Spontaneous return of sinus rhythm occurred in all ani-
mals, thus allowing the animals to be separated from CPB
after the 30-minute rewarming period. The animals’ lungs
were not ventilated during CPB or circulatory arrest. During
the subsequent 3-hour reperfusion period after termination of
CPB, the animals’ lungs were ventilated and the animals did
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not receive inotropic support. Myocardial and pulmonary
function measurements were repeated at 1, 2, and 3 hours of
reperfusion.
Myocardial function: Preload recruitable stroke work
index. Preload recruitable stroke work index (PRSWI), a
load-independent measure of cardiac function, was measured
during transient inferior vena caval occlusion.17 Left ventric-
ular pressure (Millar transducer) and segment length
(sonomicrometry crystals) were measured simultaneously
during successive cardiac cycles to generate pressure-seg-
ment length loops; each loop represents the regional myocar-
dial stroke work of a specific cardiac cycle. During caval
occlusion, a series of pressure-segment length loops were
generated as preload decreased decrementally. Regional
myocardial stroke work is linearly related to end-diastolic
segment length, and the slope of the regression of this rela-
tionship determines the PRSWI. PRSW was determined at
baseline (before hypothermic circulatory arrest) and at 1, 2,
and 3 hours of reperfusion. Each determination represented
an average of 3 caval occlusions, and regressions were excel-
lent in all animals (r2 ≥ 0.98).
Pulmonary function. The lambs’ lungs were ventilated
with a Servo 900C ventilator (Siemens) with tidal volumes of
15 mL/kg, a fraction of inspired oxygen of 1.0, and 3 cm H2O
positive end-expiratory pressure. To set a consistent lung vol-
ume history, lungs were inflated to a sustained static inflation
pressure of 40 cm H2O for 30 seconds immediately before
measurements. Pulmonary mechanics were measured with
the integrated pulmonary mechanics module for the Servo
900C ventilator (Siemens). Dynamic pulmonary compliance
was determined as expired tidal volume divided by change in
pressure (end-inspiratory pressure – positive end-expiratory
pressure). Passive expiratory airway resistance was deter-
mined as change in pressure (end-inspiratory pressure – pos-
itive end-expiratory pressure) divided by peak expiratory
flow. Pulmonary function and simultaneous arterial blood gas
measurements were made at baseline (before CPB) and 1, 2,
and 3 hours of reperfusion.
Edema formation. Samples of the left ventricle, lung, kid-
ney, and liver were harvested after 3 hours of reperfusion.
Tissue samples were weighed, desiccated in an oven for 48
hours, and reweighed. Wet/dry weight ratios were calculated
and expressed as means ± SD.
In vitro microvessel studies. Pulmonary arterioles (75-
200 µm) were dissected from the lungs of sheep by means of
a 10-60× dissecting microscope (Olympus Optical Co, Ltd,
Tokyo, Japan). In a similar manner, coronary arterial
microvessels (75-200 µm in internal diameter) were dissect-
ed from the subepicardial region of the left ventricle of each
heart. Tissue samples were immediately placed in cold
(~4°C) Krebs buffer solution. Microvessels were placed in a
Plexiglas organ chamber (Rohm and Haas Company,
Philadelphia, Pa), cannulated with dual glass micropipettes
measuring 30 to 80 µm in diameter, and secured with 10-0
nylon monofilament suture (Ethicon, Inc, Somerville, NJ). 3-
(N-morpholino) propanesulfonic acid (MOPS) buffer solu-
tion warmed to 37°C was continuously circulated through the
organ chamber and a reservoir (total fluid volume, 100 mL).
Pulmonary microvessels were pressurized to 20 mm Hg, and
coronary microvessels were pressurized to 40 mm Hg in a no-
flow state by using a burette manometer filled with MOPS
buffer solution. MOPS buffer solution was composed of the
following: NaCl, 145.0 mmol/L; KCl, 4.7 mmol/L; CaCl2,
2.0 mmol/L; MgSO4, 1.2 mmol/L; glucose, 5.0 mmol/L;
pyruvate, 2.0 mmol/L; ethylenediaminetetraacetic acid, 0.02
mmol/L; NaH2PO4, 1.2 mmol/L; and MOPS, 3.0 mmol/L.
An inverted microscope (40-200×; Olympus) was connect-
ed to a video camera, and the vessel image was projected onto
a black-and-white television monitor (Hitachi Ltd, Tokyo,
Japan). An electronic dimension analyzer (Living System
Instrumentation, Burlington, Vt) was used to measure the
internal lumen diameter. Measurements were recorded with a
strip-chart recorder. Vessels were allowed to equilibrate for at
least 30 minutes in Krebs buffer solution before a drug inter-
vention.
Relaxation responses of pulmonary and coronary
microvessels were examined after precontraction of vessels
by 20% to 60% with the thromboxane A2 analog U46619.
Once the steady-state tone was attained, the dose responses to
acetylcholine (10–9-10–4 mol/L) and sodium nitroprusside
(10–9-10–4 mol/L) were examined in pulmonary vessels, and
the responses to the calcium ionophore A23187 (10–9-10–5
mol/L) and sodium nitroprusside (10–9-10–4 mol/L) were
examined in coronary vessels. Acetylcholine was observed to
cause contraction of sheep coronary microvessels and was
therefore not used to assess endothelium-dependent relax-
ation. Drugs were applied extraluminally. Measurements
were always taken 2 to 3 minutes after the drug was adminis-
tered, when the response had stabilized. The vessels were
washed 3 times with MOPS buffer solution and allowed to
equilibrate in a drug-free buffer solution for 10 to 15 minutes
between pharmacologic interventions. 
Drugs. Acetylcholine chloride, A23187, U46619, MOPS,
and sodium nitroprusside were obtained from Sigma Chemical
Company (St Louis, Mo). U46619 was dissolved in ethanol and
water. Other drugs were dissolved in ultrapure distilled water.
All solutions were prepared on the day of the study. 
Experimental groups. The sialyl Lewisx analog (CY1503)
used in this study was provided by Cytel Corporation (San
Diego, Calif). Animals in the experimental group (CPB-
CY1503, n = 6) received CY1503 (20 mg/kg) added to the
pump prime before institution of CPB and a continuous infu-
sion (3.33 mg · kg–1 · h–1) during reperfusion to attain con-
stant levels of CY1503 before ischemia and during the entire
period of reperfusion. Control animals (CPB-saline, n = 7)
received saline vehicle alone. Control animals for in vitro
microvessel studies were anesthetized, intubated, ventilated,
and received a sham sternotomy, after which peripheral seg-
ments of lung and myocardial samples for microvessel analy-
sis were harvested.
Data analysis. Results from myocardial and pulmonary
function measurements are expressed as percentage recovery
of baseline (mean ± SD). Differences between groups were
determined by repeated-measures analysis of variance.
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The response of microvessels to each agent or pressure
intervention was examined once in each animal. Dose-
response data from each experimental group were pooled.
Differences between groups were determined by using 2-fac-
tor repeated-measures analysis of variance and the Scheffé
test post hoc. Values are expressed as means ± SEM.
Animals in this study received humane care in compliance
with the “Principles of Laboratory Animal Care” formulated
by the National Society for Medical Research and the “Guide
for the Care and Use of Laboratory Animals” prepared by the
National Academy of Sciences and published by the National
Institutes of Health (National Institutes of Health publication
No. 85-23, revised in 1985).
Results
Myocardial function and hemodynamics. There
were no baseline differences in the measured indices of
myocardial function between the two groups (Table I).
Fig 1 displays the percentage recovery of myocardial
function (PRSWI and rate of pressure rise [+dP/dt] and
fall [–dP/dt]) at 1, 2, and 3 hours’ reperfusion after CPB-
DHCA. Myocardial function was markedly depressed
throughout the 3-hour reperfusion period in untreated
lambs subjected to 2 hours of DHCA. Myocardial func-
Table I.  Baseline myocardial and pulmonary function
measurements
CPB-saline CPB-CY1503
PRSWI (erg · 103/cm3) 57 ± 11 69 ± 26
+dP/dt (mm Hg/s) 1012 ± 287 922 ± 350
–dP/dt (mm Hg/s) 892 ± 311 735 ± 391
Dynamic pulmonary 8.2 ± 2.3 9.9 ± 3.1
compliance (mL/cm H2O)
Expiratory airway resistance 22.9 ± 4.1 23.2 ± 8.0 
(cm H2O · L–1 · s–1)
Data are presented as means ± SD.
Fig 1. Myocardial contractile function in control and
CY1503-treated animals during reperfusion. The upper
panel demonstrates that PRSWI (a load-independent mea-
sure of contractile function) is greater in Cy1503-treated
animals throughout reperfusion (P = .001, overall differ-
ence between groups determined by repeated-measures
analysis of variance). The lower panels show that +dP/dt
and –dP/dt (load-dependent measures of myocardial func-
tion) are greater in CY1503-treated animals throughout
reperfusion (P = .04 and .01, respectively). Results are
expressed as the percentage recovery of baseline value
(mean ± SD).
Fig 2. Pulmonary function in control and CY1503-treated
animals during reperfusion. Although pulmonary mechanics
are not markedly impaired after CBP-DHCA, dynamic lung
compliance and expiratory airway resistance are slightly bet-
ter in CY1503-treated animals throughout reperfusion (P =
.014 and .037, respectively; overall difference between
groups determined by repeated-measures analysis of vari-
ance). Results are expressed as the percentage recovery of
baseline value (mean ± SD).
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tion was significantly preserved in CY1503-treated ani-
mals; recovery of PRSWI, +dP/dt, and –dP/dt was better
in the CY1503-treated lambs than in the untreated con-
trol animals (P = .001, .04, and .01, respectively). The
improvement in myocardial function corresponded to
greater systolic and mean arterial pressure in CY1503-
treated animals, with no difference in left atrial pressure
between groups (Table II).
Pulmonary function. Pulmonary mechanics were
not significantly impaired after CBP-DHCA (Fig 2);
dynamic lung compliance and airways resistance
approached baseline values in untreated animals dur-
ing reperfusion. In spite of this, animals treated with
CY1503 exhibited slightly better dynamic lung com-
pliance and expiratory airway resistance than did
untreated animals (repeated-measures analysis of
variance revealed overall differences between
groups: P = .014 and .037, respectively). Pulmonary gas
exchange was mildly impaired in the untreated lambs
after CPB, as demonstrated by the progressive fall in arte-
rial PO2 (PaO2) during reperfusion. Gas exchange was
better preserved in CY1503-treated animals, as demon-
strated by higher PaO2 throughout reperfusion (Table II).
Wet/dry weight ratio. No differences were noted in
wet/dry weight ratios of heart, lung, liver, or kidney
between the untreated and CY1503-treated groups
(Table III).
Vessel characteristics. Pulmonary microvessels
averaged 160 ± 9 µm, 149 ± 10 µm, and 160 ± 10 µm
in the control, CPB-saline, and CPB-CY1503 groups,
respectively. The percentage of precontraction after
application of U46619 was 45% ± 6%, 47% ± 5%, and
45% ± 3% in the control, CPB-saline, and CPB-1503
groups, respectively. Coronary microvessels averaged
181 ± 7 µm, 164 ± 9 µm, and 186 ± 6 µm in the con-
trol, CPB-saline, and CPB-CY1503 groups, respective-
ly. The percentage of precontraction after application
of U46619 was 38% ± 2%, 42% ± 2%, and 45% ± 4%
in the control, CPB-saline, and CPB-CY1503 groups,
respectively.
Pulmonary vascular responses. Pulmonary endothe-
lium–dependent microvascular relaxation to acetyl-
choline was impaired after CPB compared with the con-
trol response, whereas vessels from CY1503-treated
animals showed normal relaxation to acetylcholine (Fig
3, A). Endothelium-independent relaxation to sodium
nitroprusside was similar in all groups (Fig 3, B). 
Coronary vascular responses. Coronary endotheli-
um–dependent microvascular relaxation to the calcium
ionophore A23187 was reduced after CPB compared
with the control response, whereas vessels from
CY1503-treated animals showed normal relaxation to
A23187 (Fig 4, A). Endothelium-independent relax-
ation to sodium nitroprusside was similar in all groups
(Fig 4, B).
Discussion
Ischemia-reperfusion injury is a complex process that
occurs in multiple pathologic states, including cardio-
vascular operations, transplantation, trauma, stroke,
and myocardial infarction.2 CPB is a particularly
potent stimulus for inflammatory injury; activation of
blood components by the extracorporeal circuit may
augment tissue reperfusion injury.1,3 The inflammatory
process resulting from ischemia with subsequent reper-
fusion involves (1) neutrophil recruitment and activa-
tion and (2) release of proinflammatory cytokines,
toxic oxygen metabolites, and proteases.6 Interactions
between neutrophils and endothelium are integral to
the deleterious inflammatory process.6 The initial teth-
ering of neutrophils to endothelium is mediated by the
selectins, glycoprotein endothelial adhesion molecules
that bind to oligosaccharide ligands on neutrophils,
including sialyl Lewisx.18 P-selectin is stored pre-
formed in endothelial Weibel-Palade bodies, and sur-
face expression can occur within minutes in response to
Table II.  Hemodynamics and PaO2
CPB-saline CPB-CY 1503
Pre-CPB One-hour Two-hour Three-hour One-hour Two-hour Three-hour 
baseline reperfusion reperfusion reperfusion Pre-CPB reperfusion reperfusion reperfusion
SBP (mm Hg) 63 ± 15 43 ± 14 52 ± 16 48 ± 12 52 ± 19 52 ± 12 63 ± 16 61 ± 12*
MAP (mm Hg) 52 ± 10 28 ± 7 38 ± 12 34 ± 10 44 ± 16 35 ± 8 42 ± 14 46 ± 10
PAp (mm Hg) 20 ± 7 19 ± 8 27 ± 15 22 ± 7 15 ± 4 18 ± 6 22 ± 6 22 ± 4
LAp (mm Hg) 2 ± 2 4 ± 4 5 ± 3 3 ± 3 2 ± 2 4 ± 3 4 ± 3 4 ± 3
PaO2 585 ± 61 474 ± 161 450 ± 172 356 ± 161 509 ± 89 552 ± 108 571 ± 84 543 ± 72*
Data are presented as means ± SD. SBP, Systolic blood pressure; MAP, mean arterial pressure; PAp, mean pulmonary arterial pressure; LAp, left atrial pressure.
*P < .05 versus the CPB-saline group, as determined by repeated-measures analysis of variance.
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histamine, thrombin, complement, and hypoxia. By
contrast, E-selectin is synthesized de novo in response
to cytokines, such as interleukin 8, interleukin 1,
lipopolysaccharide, and tumor necrosis factor α; maxi-
mal expression occurs within 4 to 6 hours and persists
for 24 to 48 hours. After the initial step of selectin-
mediated leukocyte rolling, firm adhesion between
neutrophils and endothelial cells occurs through inter-
action of integrins and intercellular adhesion mole-
cules, bringing activated neutrophils into intimate con-
tact with the endothelial surface to allow local damage
to endothelium and transendothelial migration into
parenchymal tissue.6
Interruption of neutrophil-endothelial adhesion offers
the potential to abort or diminish the inflammatory
process with obvious therapeutic potential. Antibodies
to various adhesion molecules have protective effects
after myocardial ischemia-reperfusion. Monoclonal
antibodies to CD11 and CD18 reduce myocardial and
endothelial damage after global or focal ischemia.19-21
Monoclonal antibodies directed against P-selectin,22 L-
selectin,23 and intercellular adhesion molecule 124 have
been shown to improve recovery of contractile and
endothelial function and decrease neutrophil accumula-
tion after temporary coronary ligation in feline or
canine hearts.
We reasoned that blockade of selectin-mediated
neutrophil-endothelial interactions could prevent
inflammatory tissue injury after CPB and hypothermic
circulatory arrest. CY1503, a synthetic oligosaccha-
ride analog of sialyl Lewisx, is thought to reduce neu-
trophil adherence to endothelium by saturation block-
ade of selectins. CY1503 has been shown to reduce
tissue injury in multiple animal models of ischemia-
reperfusion,8-16 and the present data provide further
evidence of the protective effects of CY1503 in anoth-
er animal model. Pulmonary and coronary endothelial
dysfunction, as normally accompanies CPB, was
absent in CY1503-treated lambs subjected to CPB and
circulatory arrest. This finding correlated with signif-
icant preservation of myocardial contractile and pul-
monary function in the CPB-CY1503 group. Although
the data suggest that preservation of myocardial and
pulmonary function results from selectin blockade,
other potential mechanisms of protection cannot be
ruled out. The data are consistent with observations
made in CY1503-treated pigs undergoing CPB,25 but
cardiopulmonary and endothelial preservation associ-
ated with CY1503 treatment was more dramatic in the
neonatal lambs we studied. The greater efficacy of
Fig 3. In vitro dose responses of pulmonary microvessels to the endothelium-dependent and endothelium-inde-
pendent agonists acetylcholine (A) and sodium nitroprusside (B) in control, CPB-saline, and CPB-CY1503 groups
(displayed as log to the base 10 of the specific vasodilator). Vessels were precontracted with U46619, and respons-
es are given as percentage relaxation of U46619-induced vessel contraction. CPB with circulatory arrest resulted
in significant pulmonary endothelial dysfunction, which was prevented by CY1503 treatment. Asterisks indicate
overall difference in dose response of the control and CPB-CY1503 groups compared with the CPB-saline group,
as determined by repeated-measures analysis of variance and the Scheffé test post hoc (P < .01).
Table III.  Wet/dry weight ratios
Heart Lung Kidney Liver
CPB-saline 1.38 ± 0.30 2.42 ± 0.89 2.75 ± 0.86 2.05 ± 0.77
CPB-CY1503 1.41 ± 0.26 1.84 ± 0.67 2.05 ± 0.45 1.66 ± 0.31
Data are presented as means ± SD.
A B
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CY1503 in neonatal lambs may be an age- or species-
dependent effect. Alternatively, CY1503 was given in
the present study before CPB-DHCA and continuous-
ly during reperfusion, whereas in the previous study it
was given as a 1-time bolus before aortic crossclamp
removal. It seems likely that microvascular distribu-
tion of CY1503 is more homogeneous when given
before ischemia, and maintaining continuous levels of
the oligosaccharide during reperfusion may also be
necessary for optimal efficacy. Our findings are also
consistent with those of multiple animal myocardial
infarction studies, which have demonstrated that
CY1503 treatment before reperfusion reduces infarct
size and neutrophil accumulation while improving
cardiac contractility and endothelium-dependent
vasodilation.8-11 Similarly, CY1503 has also been
shown to reduce tissue injury in animal models of
acute lung injury,12-14 trauma,15 transplantation,12,16
and septic shock.13
Preservation of endothelial function by CY1503 is a
significant observation of this study. The endothelium
appears to be an early target of the reperfusion-related
inflammatory process, and endothelial dysfunction
occurs early after ischemia-reperfusion.10,26,27
Regional and global myocardial ischemia-reperfusion
impairs endothelium-dependent vasoreactivity and
increases capillary permeability.10,22,28 Endothelial
injury during reperfusion may precede damage to the
myocardium, and interventions that preserve endothe-
lial function have been associated with improved
myocardial contractile function.28,29 It is unclear in
these studies whether preservation of endothelial func-
tion is causative or correlative, but the results of
Tofukuji and colleagues25 might suggest the latter.
Endothelial dysfunction and concomitant alterations in
vascular reactivity are widely known sequelae of
CPB,26,30 and preservation of endothelial function in
lambs receiving CY1503 is thus notable. 
In conclusion, the present study demonstrates the
potential utility of antiadhesion therapy in neonatal ani-
mals subjected to CPB with DHCA. Our findings suggest
that selectin-mediated neutrophil-endothelial interactions
play an important role in cardiopulmonary and endothe-
lial dysfunction after DHCA in neonatal lambs. Blockade
of the inflammatory process by agents that interfere with
leukocyte-endothelial interactions may help optimize
organ preservation during cardiac operations.
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